Company / Operating Cash Flow per Share
Insulet Corporation Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$8.11
FY2025
5-year range
-$1.03 / $8.11
FY2021-FY2025
Trend
+31.8%
vs FY2024
Sector context
#34 of 155
Health Care
What the data says
Insulet Corporation's operating cash flow per share of $8.11 is higher than 78% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 4 consecutive years, from $-1.03 in FY2021 to $8.11 in FY2025.
Based on SEC 10-K filings.
8.11 in FY2025 with a 5-year CAGR of +43.3%. Top quartile in the Health Care sector.
Improved from $2.10 to $8.11 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +67.7%
- 5-Year CAGR
- +43.3%
- 10-Year CAGR
- -
Sector benchmark
+19.7% above sector average
Key checks
Key Insights
- Insulet Corporation's operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 31.8% year-over-year.
- Ranks #34 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.11 | +31.8% |
| FY2024 | $6.15 | +193.6% |
| FY2023 | $2.10 | +21.9% |
| FY2022 | $1.72 | +266.8% |
| FY2021 | -$1.03 | -177.0% |
| FY2020 | $1.34 | -19.4% |
| FY2019 | $1.66 | +170.1% |
| FY2018 | $0.62 | -14.4% |
| FY2017 | $0.72 | +157.3% |
| FY2016 | $0.28 | +225.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026